Literature DB >> 19367510

Cannabinoids and appetite: food craving and food pleasure.

Tim C Kirkham1.   

Abstract

The ability of Cannabis sativa to promote eating has been documented for many centuries, with the drug reported by its users to promote strong cravings for, and an intensification of the sensory and hedonic properties of food. These effects are now known to result from the actions of cannabinoid molecules at specific cannabinoid receptor sites within the brain, and to reflect the physiological role of their natural ligands, the endocannabinoids, in the control of appetite. Recent developments in the biochemistry and pharmacology of endocannabinoid systems have generated convincing evidence from animal models for a normal role of endocannabinoids in the control of eating motivation. The availability of specific cannabinoid receptor agonists and antagonists raises the possibility of improved therapies for disorders of eating and body weight: not only in the suppression of appetite to counter our susceptibility to the over-consumption of highly pleasurable and energy-dense foods; but also in the treatment of conditions that involve reduced appetite and weight loss. Here, we outline some of the findings of the past decade that link endocannabinoid function appetite control, and the possible clinical applications of that knowledge.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19367510     DOI: 10.1080/09540260902782810

Source DB:  PubMed          Journal:  Int Rev Psychiatry        ISSN: 0954-0261


  44 in total

1.  2-arachidonoylglycerol signaling in forebrain regulates systemic energy metabolism.

Authors:  Kwang-Mook Jung; Jason R Clapper; Jin Fu; Giuseppe D'Agostino; Ana Guijarro; Dean Thongkham; Agnesa Avanesian; Giuseppe Astarita; Nicholas V DiPatrizio; Andrea Frontini; Saverio Cinti; Sabrina Diano; Daniele Piomelli
Journal:  Cell Metab       Date:  2012-03-07       Impact factor: 27.287

2.  Ligand-induced internalization of the orexin OX(1) and cannabinoid CB(1) receptors assessed via N-terminal SNAP and CLIP-tagging.

Authors:  Richard J Ward; John D Pediani; Graeme Milligan
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

3.  The peptide hemopressin acts through CB1 cannabinoid receptors to reduce food intake in rats and mice.

Authors:  Garron T Dodd; Giacomo Mancini; Beat Lutz; Simon M Luckman
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

4.  The endocannabinoid system modulates the valence of the emotion associated to food ingestion.

Authors:  Mónica Méndez-Díaz; Pavel Ernesto Rueda-Orozco; Alejandra Evelyn Ruiz-Contreras; Oscar Prospéro-García
Journal:  Addict Biol       Date:  2010-12-23       Impact factor: 4.280

5.  Molecular annotation of integrative feeding neural circuits.

Authors:  Cristian A Pérez; Sarah A Stanley; Robert W Wysocki; Jana Havranova; Rebecca Ahrens-Nicklas; Frances Onyimba; Jeffrey M Friedman
Journal:  Cell Metab       Date:  2011-02-02       Impact factor: 27.287

6.  Rimonabant abolishes sensitivity to workload changes in a progressive ratio procedure.

Authors:  Julie A Marusich; Jenny L Wiley
Journal:  Pharmacol Biochem Behav       Date:  2012-03-09       Impact factor: 3.533

7.  Low dose naloxone attenuates the pruritic but not anorectic response to rimonabant in male rats.

Authors:  F L Wright; R J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  2012-11-10       Impact factor: 4.530

8.  Inhaling: endocannabinoids and food intake.

Authors:  Jaime G Maldonado-Avilés; Ralph J Dileone
Journal:  Nat Neurosci       Date:  2014-03       Impact factor: 24.884

9.  Diets rich in saturated fat and fructose induce anxiety and depression-like behaviours in the rat: is there a role for lipid peroxidation?

Authors:  Silvia Gancheva; Bistra Galunska; Maria Zhelyazkova-Savova
Journal:  Int J Exp Pathol       Date:  2017-12-06       Impact factor: 1.925

10.  Structural equation modeling of food craving across the menstrual cycle using behavioral, neuroendocrine, and metabolic factors.

Authors:  Sridevi Krishnan; Karan Agrawal; Rebecca R Tryon; Lucas C Welch; William F Horn; John W Newman; Nancy L Keim
Journal:  Physiol Behav       Date:  2018-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.